Repeated subarachnoid administrations of autologous mesenchymal stromal cells supported in autologous plasma improve quality of life in patients suffering incomplete spinal cord injury.

导出 LinkOut

翻译打印收藏纠错

作者： Jesús,Vaquero ^[1] ; Mercedes,Zurita ^[2] ; Miguel A,Rico ^[2] ; Celia,Bonilla ^[2] ; Concepción,Aguayo ^[2] ; Cecilia,Fernández ^[3] ; Noemí,Tapiador ^[4] ; Marta,Sevilla ^[4] ; Carlos,Morejón ^[4] ; Jesús,Montilla ^[4] ; Francisco,Martínez ^[5] ; Esperanza,Marín ^[5] ; Salvador,Bustamante ^[6] ; David,Vázquez ^[6] ; Joaquín,Carballido ^[6] ; Alicia,Rodríguez ^[2] ; Paula,Martínez ^[2] ; Coral,García ^[7] ; Mercedes,Ovejero ^[8] ; Marta V,Fernández ^[2] ; Neurological Cell Therapy Group

作者单位： Neurosurgery Service, University Hospital Puerta de Hierro-Majadahonda, Autonomous University, Madrid, Spain; Neuroscience Research Unit, University Hospital Puerta de Hierro-Majadahonda, Autonomous University, Madrid, Spain. Electronic address: jvaqueroc@telefonica.net. ^[1] Neuroscience Research Unit, University Hospital Puerta de Hierro-Majadahonda, Autonomous University, Madrid, Spain. ^[2] Neurosurgery Service, University Hospital Puerta de Hierro-Majadahonda, Autonomous University, Madrid, Spain. ^[3] Rehabilitation Service, University Hospital Puerta de Hierro-Majadahonda, Autonomous University, Madrid, Spain. ^[4] Clinical Neurophysiology Service, University Hospital Puerta de Hierro-Majadahonda, Autonomous University, Madrid, Spain. ^[5] Urology Service, University Hospital Puerta de Hierro-Majadahonda, Autonomous University, Madrid, Spain. ^[6] Neuroimmunology Unit, University Hospital Puerta de Hierro-Majadahonda, Autonomous University, Madrid, Spain. ^[7] Sermes CRO, Madrid, Spain. ^[8]

关键词 SCI cell therapy mesenchymal stromal cells